Showing results (311-320 of 380) with videos related to
Sort By:
Pageof 38
Lancet (London, England)|June 15, 1985
Dimensional accuracy of magnetic resonance in studies of the heartD B Longmore, R H Klipstein, S R Underwood, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2026
Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED)Hongyi Qin, Linda Pointon, James Carpenter, et al.Biochemistry|October 21, 1998
Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: immunodetection of alpha-, beta-, and gamma-secretase productsD Le Brocque, A Henry, R Cappai, et al.Journal of Neuroscience Research|October 23, 1997
Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartmentJ G Culvenor, F Maher, G Evin, et al.Circulation|March 12, 1998
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricleR R Kaprielian, M Gunning, E Dupont, et al.Human Molecular Genetics|December 22, 2005
Rapamycin alleviates toxicity of different aggregate-prone proteinsZdenek Berger, Brinda Ravikumar, Fiona M Menzies, et al.BMC Musculoskeletal Disorders|January 30, 2007
Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disordersSarah E Lamb, Simon Gates, Martin R Underwood, et al.British Heart Journal|August 1, 1995
Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery diseaseD J Pennell, D N Firmin, P Burger, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
In vitro activities of benzimidazole D- and L-ribonucleosides against herpesvirusesStephanie L Williams, Caroll B Hartline, Nicole L Kushner, et al.Journal of Neurology|October 28, 2017
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's diseaseBenjamin R Underwood, Zeyn W Green-Thompson, Peter J Pugh, et al.Pageof 38